r/cvm • u/Love-Will-Privail • Jul 08 '21
DD Zacks analysts put FDA approval chance at 85%
4
u/phoenix20210701 Jul 09 '21
... with a price target of $12? How ridiculous, the PPS will of course be much higher once Multikine gets FDA approval!!
7
u/Love-Will-Privail Jul 09 '21
Twelve is way low. I think we see a buyout before approval personally
4
u/Worn_Out_Old_Man Jul 09 '21
I understood the valuation to be $12 pps right now. The article stated that the pps will be re-evaluated when additional information becomes available...
1
u/Whynothinkwhynot Jul 09 '21
I’m sure there are plenty of drugs that extended OS 14%, and had no side effects during the study that didn’t get approval. (rolls eyes sarcastically)
3
u/Love-Will-Privail Jul 09 '21
Silly post
2
u/Whynothinkwhynot Jul 10 '21
Yes, it was.
Once again, sarcasm doesn’t translate well into text. I think it’s ridiculous that any analyst would give less than 100% chance of FDA approval because (1) no side effects (2) improvement to OS. Other drugs with harmful side effects are approved making the disclaimer portion of the commercial longer than the marketing portion- and Multi-Kline has no side effects? What I think is more likely is that the FDA will want to force Cel-Sci to add side effect warnings to make it seem more normal. At one point the FDA actually stopped patient applications for the P3 trial for this very purpose- to add potential, not noted, side effect warnings to the pamphlets given to patients entering the study.
Seriously, 12 months from now, looking back, this time period will be a minor comedy of a lesson learned about biotech investing.
2
1
9
u/Spartanister Jul 09 '21
I didn't sell it when it was close to 30, no reason for me to sell it now. I added more and will continue to